Preview: Ginkgo Bioworks Holdings's Earnings
Portfolio Pulse from Benzinga Insights
Ginkgo Bioworks Holdings (NYSE:DNA) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.09. The company's past performance shows a trend of missing EPS estimates, which has led to drops in share price. The company's shares are currently trading at $1.52 and have seen a 31.52% decrease over the last 52-week period.
November 07, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ginkgo Bioworks Holdings is expected to report an EPS of $-0.09. The company's history of missing EPS estimates and subsequent share price drops could potentially impact the stock negatively.
Ginkgo Bioworks has a history of missing EPS estimates, which has led to significant drops in its share price. Given this trend and the analysts' estimate of an EPS of $-0.09, there is a high likelihood that the company's stock could be negatively impacted following the earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100